Reacciones Adversas Asociadas a la Administración de Fármacos Oncológicos en Pacientes Atendidos en el Hospital Militar Central Lima 2024.
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Privada de Huancayo Franklin Roosevelt
DOI
Abstract
La investigación tiene como objetivo evaluar las reacciones adversas asociadas a la administración de fármacos oncológicos en pacientes atendidos en el Hospital Militar Central Lima 2024. Estudio de tipo básico, descriptivo, transversal, no experimental, la muestra lo constituyeron 86 pacientes del servicio de oncología. Los resultados mostraron que el 45,3% son mayores de 45 años, el 61,6% son del sexo masculino y el 27,9% fueron diagnosticados con cáncer de próstata. Se evaluó la frecuencia e incremento de las reacciones adversas, donde el 52,3% presentaron reacciones adversas condicional y solo el 18,6% presentaron incremento de reacciones adversas, observándose que no fue significativo, En conclusión, la edad ni el sexo influyen en la aparición de reacciones adversas en estos pacientes.
The objective of this study was to evaluate the adverse reactions associated with the administration of oncological drugs in patients treated at the Hospital Militar Central Lima 2024. A basic, descriptive, cross-sectional, non-experimental study, the sample consisted of 86 patients from the oncology service. The results showed that 45.3% were older than 45 years, 61.6% were male and 27.9% were diagnosed with prostate cancer. The frequency and increase of adverse reactions were evaluated, where 52.3% presented conditional adverse reactions and only 18.6% presented an increase in adverse reactions, which was not significant.
The objective of this study was to evaluate the adverse reactions associated with the administration of oncological drugs in patients treated at the Hospital Militar Central Lima 2024. A basic, descriptive, cross-sectional, non-experimental study, the sample consisted of 86 patients from the oncology service. The results showed that 45.3% were older than 45 years, 61.6% were male and 27.9% were diagnosed with prostate cancer. The frequency and increase of adverse reactions were evaluated, where 52.3% presented conditional adverse reactions and only 18.6% presented an increase in adverse reactions, which was not significant.
Description
Keywords
Citation
Vancouver